Nanoparticulate systems for brain delivery of drugs.

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

Cordon‐Cardo, C., O’Brien, J. P., Casals, D., Rittmann-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693

Brain drug delivery of small molecules using immunoliposomes

Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 660

An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro

Dehouck, M., Méresse, S., Delorme, P., Fruchart, J., & Cecchelli, R. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01236.x · Cited by 548

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Aa, I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 538

Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles

Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521

A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier

Dehouck, B., Fenart, L., Dehouck, M.-P., Pierce, A., Torpier, G., & Cecchelli, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.877 · Cited by 490

Hyperalgesia Induced by Naloxone Follows Diurnal Rhythm in Responsivity to Painful Stimuli

Frederickson, R. C. A., Burgis, V., & Edwards, J. D. (1977) · Science · doi:10.1126/science.561998 · Cited by 379

Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.

Pardridge, W. M., Buciak, J. L., & Friden, P. M. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20567-5 · Cited by 358

Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles

Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352

Anti-HIV-1 nanotherapeutics: promises and challenges for the future

Mahajan, S. D., Law, W., Aalinkeel, Reynolds, Nair, Sykes, Yong, K., Roy, Prasad, P. N., & Schwartz, S. A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s25871 · Cited by 134

Novel Formulations for Antimicrobial Peptides

Carmona‐Ribeiro, A. M., & Carrasco, L. D. D. M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018040 · Cited by 141

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats

Ambruosi, A., Khalansky, A. S., Yamamoto, H., Gelperina, S. E., Begley, D. J., & Kreuter, J. (2006) · Journal of Drug Targeting · doi:10.1080/10611860600636135 · Cited by 119

Comparison of Nanotube–Protein Corona Composition in Cell Culture Media

Shannahan, J. H., Brown, J. M., Chen, R., Ke, P. C., Lai, X., Mitra, S., & Witzmann, F. A. (2013) · Small · doi:10.1002/smll.201202243 · Cited by 135

Hydroxypyridinones as “privileged” chelating structures for the design of medicinal drugs

Santos, M. A., Marques, S. M., & Chaves, S. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.08.008 · Cited by 131

Influence of titanium dioxide nanoparticles on speciation and bioavailability of arsenite

Sun, H., Zhang, X., Zhang, Z., Chen, Y., & Crittenden, J. C. (2008) · Environmental Pollution · doi:10.1016/j.envpol.2008.08.022 · Cited by 132

Use of Nanoparticles for Cerebral Cancer

Kreuter, J., & Gelperina, S. E. (2008) · Tumori Journal · doi:10.1177/030089160809400220 · Cited by 131

Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor

Aktaş, Y., Andrieux, K., Alonso, M. J., Calvo, P., Gürsoy, R. N., Couvreur, P., & Çapan, Y. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.027 · Cited by 135

Particle Targeting in Complex Biological Media

Dai, Q., Bertleff‐Zieschang, N., Braunger, J. A., Björnmalm, M., Cortez‐Jugo, C., & Caruso, F. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700575 · Cited by 132

Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s Disease

Monge-Fuentes, V., Mayer, A. B., Lima, M. R., Geraldes, L., Zanotto, L., Moreira, K., Martins, O., Piva, H. L., Felipe, M., Amaral, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94175-8 · Cited by 105

Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model

Wang, C., Le-song, H., Hou, L., Jiang, L., Yan, Z.-T., Wang, Y.-L., & Chen, Z.-L. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.011 · Cited by 129

Engineering Smart Targeting Nanovesicles and Their Combination with Hydrogels for Controlled Drug Delivery

Elkhoury, K., Koçak, P., Kang, A., Arab‐Tehrany, E., Ward, J. E., & Shin, S. R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090849 · Cited by 132

Methotrexate-loaded chitosan nanogels as ‘Trojan Horses’ for drug delivery to brain: Preparation and in vitro/in vivo characterization

Azadi, A., Hamidi, M., & Rouini, M. R. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.10.004 · Cited by 127

Dextran–doxorubicin/chitosan nanoparticles for solid tumor therapy

Bisht, S., & Maitra, A. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.43 · Cited by 127

Dual and multi-targeted nanoparticles for site-specific brain drug delivery

Luo, Y., Yang, H., Zhou, Y., & Hu, B. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.11.037 · Cited by 132

Functional Protein Delivery into Neurons Using Polymeric Nanoparticles

Hasadsri, L., Kreuter, J., Hattori, H., Iwasaki, T., & George, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805956200 · Cited by 129

Improved Neuroprotective Effects of Resveratrol-Loaded Polysorbate 80-Coated Poly(Lactide) Nanoparticles in MPTP-Induced Parkinsonism

Lindner, G. D. R., Santos, D. B., Colle, D., Moreira, E. L. G., Prediger, R. D., Farina, M., Khalil, N. M., & Mainardes, R. M. (2015) · Nanomedicine · doi:10.2217/nnm.14.165 · Cited by 126

Anti-fouling magnetic nanoparticles for siRNA delivery

Boyer, C. A., Priyanto, P., Davis, T. P., Pissuwan, D., Bulmuş, V., Kavallaris, M., Teoh, W. Y., Amal, R., Carroll, M., Woodward, R. C., et al. (2009) · Journal of Materials Chemistry · doi:10.1039/b914063h · Cited by 125

Surfactants, not size or zeta-potential influence blood–brain barrier passage of polymeric nanoparticles

Voigt, N., Henrich‐Noack, P., Kockentiedt, S., Hintz, W., Tomas, J., & Sabel, B. A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.013 · Cited by 124

Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.

Markoutsa, E., Pampalakis, G., Niarakis, A., Romero, I. A., Weksler, B., Couraud, P.-O., & Antimisiaris, S. G. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.015 · Cited by 122

Nanotechnology and Nanotoxicology

Curtis, J. A., Greenberg, M., Kester, J. E., Phillips, S., & Krieger, G. R. (2006) · Toxicological Reviews · doi:10.2165/00139709-200625040-00005 · Cited by 124

Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier

Silva, G. A. (2007) · Surgical Neurology · doi:10.1016/j.surneu.2006.08.033 · Cited by 119

Systemically Administered Brain-Targeted Nanoparticles Transport Peptides across the Blood—Brain Barrier and Provide Neuroprotection

Yemisci, M., Caban, S., Gursoy-Ozdemir, Y., Lule, S., Novoa-Carballal, R., Riguera, R., Fernandez-Megia, E., Andrieux, K., Couvreur, P., Capan, Y., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.220 · Cited by 118

Brain delivery of camptothecin by means of solid lipid nanoparticles: Formulation design, in vitro and in vivo studies

Martins, S., Tho, I., Reimold, I., Fricker, G., Souto, E. B., Ferreira, D., & Brandl, M. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.054 · Cited by 117

Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines

Wang, J., Hu, X.-B., & Xiang, D. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1477857 · Cited by 117

Double-Coated Poly (Butylcynanoacrylate) Nanoparticulate Delivery Systems for Brain Targeting of Dalargin Via Oral Administration

Das, D., & Lin, S. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20357 · Cited by 117

Preparation and in vitro / in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles

Zu, Y., Zhang, Y., Wang, W., Zhao, X., Han, X., Wang, K., & Ge, Y. (2014) · Drug Delivery · doi:10.3109/10717544.2014.924167 · Cited by 116

Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tumors

Bhujbal, S. V., de Vos, P., & Niclou, S. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.010 · Cited by 116

Nanoparticles for antiparasitic drug delivery

Sun, Y., Chen, D., Pan, Y., Qu, W., Hao, H., Wang, X., Liu, Z., & Xie, S. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1692968 · Cited by 116

Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: In vitro and in vivo evaluation

Kaur, A., Jain, S. K., & Tiwary, A. K. (2008) · Acta Pharmaceutica · doi:10.2478/v10007-007-0045-1 · Cited by 116

Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB

Nagpal, K., Singh, S. K., & Mishra, D. N. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.762354 · Cited by 119

Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment

Singh, S. K., Dadhania, P., Vuddanda, P. R., Jain, A., Velaga, S. P., & Singh, S. K. (2016) · RSC Advances · doi:10.1039/c5ra19793g · Cited by 116

Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles

Patel, M., Souto, E. B., & Singh, K. K. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.784742 · Cited by 114

Neurological disorders and therapeutics targeted to surmount the blood–brain barrier

Kanwar, J. R., Sriramoju, & Kanwar (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30919 · Cited by 114

Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route

Shah, B., Khunt, D., Misra, M., & Padh, H. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.04.076 · Cited by 112

Impact of Gold Nanoparticles on Amyloid β-Induced Alzheimer’s Disease in a Rat Animal Model: Involvement of STIM Proteins

Sanati, M., Khodagholi, F., Aminyavari, S., Ghasemi, F., Gholami, M., Kebriaeezadeh, A., Sabzevari, O., Hajipour, M. J., Imani, M., Mahmoudi, M., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00622 · Cited by 113

Engineered nanoparticles, How brain friendly is this new guest?

Cupaioli, F. A., Zucca, F. A., Boraschi, D., & Zecca, L. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.05.002 · Cited by 139

Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles

Kuo, Y., & Ko, H.-F. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.013 · Cited by 110

Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer's disease

Liu, Y., Zhou, H., Yin, T., Gong, Y., Yuan, G., Chen, L., & Liu, J. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2019.05.066 · Cited by 113

Effects of Surface Modification on Delivery Efficiency of Biodegradable Nanoparticles Across The Blood–Brain Barrier

Kulkarni, S. A., & Feng, S. (2011) · Nanomedicine · doi:10.2217/nnm.10.131 · Cited by 111

Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration

Cai, Z., Hou, S., Li, Y., Zhao, B., Yang, Z., Xu, S., & Pu, J. (2008) · Journal of drug targeting · doi:10.1080/10611860701794395 · Cited by 110

In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma

de Mendoza, A. E., Véronique Préat, A., Mollinedo, F., & Blanco‐Prieto, M. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.030 · Cited by 110

Drug Delivery to the Ischemic Brain

Thompson, B. J., & Ronaldson, P. T. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.013 · Cited by 111

Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate–sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood–brain barrier

Kuo, Y., & Chen, H.-H. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.044 · Cited by 109

Nanotechnology-based drug delivery for the treatment of CNS disorders

Mittal, K. R., Pharasi, N., Sarna, B., Singh, M., Rachana, R., Haider, S., Singh, S. K., Dua, K., Jha, S. K., Dey, A., et al. (2022) · Translational Neuroscience · doi:10.1515/tnsci-2022-0258 · Cited by 118

Nanoparticulate Vanadium Oxide Potentiated Vanadium Toxicity in Human Lung Cells

Wörle‐Knirsch, J. M., Kern, K., Schleh, C., Adelhelm, C., Feldmann, C., & Krug, H. F. (2006) · Environmental Science & Technology · doi:10.1021/es061140x · Cited by 108

N‐vinylcaprolactam‐based microgels for biomedical applications

Imaz, A., & Forcada, J. (2010) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.23876 · Cited by 108

Application of nanoparticles for the delivery of drugs to the brain

Kreuter, J. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.014 · Cited by 107

Modulation of Drug Transporters at the Blood-Brain Barrier

Fricker, G., & Miller, D. S. (2004) · Pharmacology · doi:10.1159/000075545 · Cited by 106

Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood–brain barrier

Chen, Y., Hsieh, W.-Y., Lee, W., & Zeng, D.-T. (2011) · Journal of Biomaterials Applications · doi:10.1177/0885328211429495 · Cited by 107

Medicinal Chemistry Based Approaches and Nanotechnology‐Based Systems to Improve CNS Drug Targeting and Delivery

Vlieghe, P., & Khrestchatisky, M. (2012) · Medicinal Research Reviews · doi:10.1002/med.21252 · Cited by 109

Apolipoprotein A-I coating of protamine–oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood–brain barrier

Kratzer, I., Wernig, K., Panzenboeck, U., Bernhart, E. M., Reicher, H., Wronski, R., Windisch, M., Hammer, A., Malle, E., Zimmer, A., et al. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.020 · Cited by 106

Development of a Smart Nano-vehicle to Target Cerebrovascular Amyloid Deposits and Brain Parenchymal Plaques Observed in Alzheimer’s Disease and Cerebral Amyloid Angiopathy

Agyare, E. K., Curran, G. L., Ramakrishnan, M., Yu, C. C., Poduslo, J. F., & Kandimalla, K. K. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9688-y · Cited by 104

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents

Biddlestone-Thorpe, L., Marchi, N., Guo, K., Ghosh, C., Janigro, D., Valerie, K. C., & Yang, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.014 · Cited by 103

Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration

Manjunath, K., & Venkateswarlu, V. (2006) · Journal of drug targeting · doi:10.1080/10611860600888850 · Cited by 103

Poloxamers for Surface Modification of Hydrophobic Drug Carriers and Their Effects on Drug Delivery

Shubhra, Q. T. H., Tóth, J. S., Gyenis, J., & Feczkó, T. (2014) · Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics/Journal of macromolecular science. Reviews in macromolecular chemistry and physics · doi:10.1080/15583724.2013.862544 · Cited by 102

Magnetic nanoparticles in cancer diagnosis and treatment: a review

Fathi‐karkan, S., Mohammadhosseini, M., Panahi, Y., Milani, M., Zarghami, N., Akbarzadeh, A., Abasi, E., Hosseini, A., & Davaran, S. (2016) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2016.1153483 · Cited by 102

Biosynthesis of Yttrium oxide nanoparticles using Acalypha indica leaf extract

Kannan, S. K., & Sundrarajan, M. (2015) · Bulletin of Materials Science · doi:10.1007/s12034-015-0927-7 · Cited by 101

Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?

Costantino, L., & Boraschi, D. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.028 · Cited by 103

Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles

Han, L., Cai, Q., Tian, D., Kong, D. K., Gou, X., Chen, Z., Strittmatter, S. M., Wang, Z., Sheth, K. N., & Zhou, J. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.03.005 · Cited by 101

Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region

Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Hamano, N., Li, S., Chougule, M. B., Shoyele, S., Gupta, U. D., Ajazuddin, M., et al. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1471058 · Cited by 101

Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neurons

Townsend, S. A., Evrony, G. D., Gu, F., Schulz, M. P., Brown, R. H., & Langer, R. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.011 · Cited by 101

Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring

Perlstein, B., Ram, Z., Daniels, D., Ocherashvilli, A., Roth, Y., Margel, S., & Mardor, Y. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-002 · Cited by 101

Use of nanoparticles for drug delivery in glioblastoma multiforme

Jain, K. K. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.4.363 · Cited by 99

Targeting the CNS to treat type 2 diabetes

Sandoval, D. A., Obici, S., & Seeley, R. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2874 · Cited by 101

Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective

Soni, S., Ruhela, R. K., & Medhi, B. (2016) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2016.044 · Cited by 103

The Potential of Stimuli-Responsive Nanogels in Drug and Active Molecule Delivery for Targeted Therapy

Vicario‐de‐la‐Torre, M., & Forcada, J. (2017) · Gels · doi:10.3390/gels3020016 · Cited by 104

Antibody Delivery for Intracellular Targets: Emergent Therapeutic Potential

Singh, K., Ejaz, W., Dutta, K., & Thayumanavan, S. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00025 · Cited by 104

Polymeric Nanoparticles for the Treatment of Malignant Gliomas

Mahmoud, B. S., Alamri, A. H., & McConville, C. (2020) · Cancers · doi:10.3390/cancers12010175 · Cited by 104

Artificial cells: building bioinspired systems using small-scale biology

Zhang, Y., Ruder, W. C., & LeDuc, P. R. (2007) · Trends in biotechnology · doi:10.1016/j.tibtech.2007.09.006 · Cited by 100

Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system

Silva, G. A. (2005) · Surgical Neurology · doi:10.1016/j.surneu.2004.06.008 · Cited by 100

Drug delivery strategies for the treatment of malignant gliomas

Allhenn, D., Boushehri, M. A. S., & Lamprecht, A. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.06.025 · Cited by 101

Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model

Ambruosi, A., Gelperina, S. E., Khalansky, A. S., Tanski, S., Theisen, A., & Kreuter, J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600788080 · Cited by 106

Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier

Wohlfart, S., Khalansky, A. S., Gelperina, S. E., Begley, D. J., & Kreuter, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.010 · Cited by 102

Shuttle‐Mediated Nanoparticle Delivery to the Blood–Brain Barrier

Guarnieri, D., Falanga, A., Muscetti, O., Tarallo, R., Fusco, S., Galdiero, M., Galdiero, S., & Netti, P. A. (2012) · Small · doi:10.1002/smll.201201870 · Cited by 99

Nanotechnology in Cosmetics

Nafisi, S., & Maibach, H. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802005-0.00022-7 · Cited by 99

The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model

Dilnawaz, F., Singh, A., Mewar, S., Sharma, U., Jagannathan, N. R., & Sahoo, S. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.046 · Cited by 102

Transport Of Surface‐Modified Nanoparticles Through Cell Monolayers

Koch, A., Reynolds, F., Merkle, H. P., Weissleder, R., & Josephson, L. (2005) · ChemBioChem · doi:10.1002/cbic.200400174 · Cited by 99

A series of novel chitosan derivatives: Synthesis, characterization and micellar solubilization of paclitaxel

Yao, Z., Zhang, C., Ping, Q., & Yu, L. L. (2006) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2006.08.023 · Cited by 99

Differential receptor-mediated drug targeting to the diseased brain

Rip, J., Schenk, G., & de Boer, A. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902806383 · Cited by 98

Targeting anti-HIV drugs to the CNS

Rao, K. S., Ghorpade, A., & Labhasetwar, V. D. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903081705 · Cited by 100

Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats

Khan, Z. A., & Bagad, M. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s80706 · Cited by 98

Lipid-based nanoformulations in the treatment of neurological disorders

Pottoo, F. H., Sharma, S., Javed, M. N., Barkat, M. A., Harshita, Alam, M. S., Naim, M. J., Alam, O., Ansari, M. A., Barreto, G. E., et al. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1726942 · Cited by 98

Impact of the protein corona on nanomaterial immune response and targeting ability

Digiacomo, L., Pozzi, D., Palchetti, S., Zingoni, A., & Caracciolo, G. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1615 · Cited by 96

Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation

Đorđević, S. M., Cekic, N. D., Savić, M. M., Isailović, T. M., Randjelovic, D. V., Marković, B. D., Savic, S. R., Stamenić, T. T., Daniels, R., & Savic, S. D. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.007 · Cited by 95

Nanoparticle and Iron Chelators as a Potential Novel Alzheimer Therapy

Liu, G., Men, P., Perry, G. L., & Smith, M. A. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-029-8_8 · Cited by 96

Engineering a Biocompatible Scaffold with Either Micrometre or Nanometre Scale Surface Topography for Promoting Protein Adsorption and Cellular Response

Le, X., Poinern, G. E. J., Ali, N., Berry, C., & Fawcett, D. (2013) · International Journal of Biomaterials · doi:10.1155/2013/782549 · Cited by 94

Nanoparticle-Based in Vivo Investigation on Blood−Brain Barrier Permeability Following Ischemia and Reperfusion

Yang, C., Chang, C.-H., Tsai, P., Chen, W., Tseng, F., & Lo, L. (2004) · Analytical Chemistry · doi:10.1021/ac035491v · Cited by 95

Magnetic Nanoparticles Cross the Blood-Brain Barrier: When Physics Rises to a Challenge

Busquets, M. A., Espargaró, A., Sabaté, R., & Estelrich, J. (2015) · Nanomaterials · doi:10.3390/nano5042231 · Cited by 100

Transcellular brain drug delivery: A review on recent advancements

Azarmi, M., Maleki, H., Nikkam, N., & Malekinejad, H. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119582 · Cited by 96

Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles

Liu, M., Li, H., Luo, G., Liu, Q., & Wang, Y. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-1191-8 · Cited by 94

CNS drug delivery: Opioid peptides and the blood-brain barrier

WITT, K. A., & Davis, T. P. (2006) · The AAPS Journal · doi:10.1208/aapsj080109 · Cited by 95

Effect of a nano-sized natural clinoptilolite modified by the hexadecyltrimethyl ammonium surfactant on cephalexin drug delivery

Nezamzadeh‐Ejhieh, A., & Tavakoli-Ghinani, S. (2013) · Comptes Rendus Chimie · doi:10.1016/j.crci.2013.07.009 · Cited by 94

Synthesis and Cytotoxicity of Y2O3 Nanoparticles of Various Morphologies

Andelman, T., Gordonov, S., Busto, G., Moghe, P. V., & Riman, R. E. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9445-0 · Cited by 94

Preparation of Uniform-Sized Multiple Emulsions and Micro/Nano Particulates for Drug Delivery by Membrane Emulsification

Liu, W., Yang, X., & Ho, W. S. W. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22272 · Cited by 94

Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment

Chirio, D., Gallarate, M., Peira, E., Battaglia, L., Muntoni, E., Riganti, C., Biasibetti, E., Capucchio, M. T., Valazza, A., Panciani, P. P., et al. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.10.017 · Cited by 94

Nanoparticulate Systems for Drug Delivery and Targeting to the Central Nervous System

Craparo, E. F., Bondı̀, M. L., Pitarresi, G. L., & Cavallaro, G. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00199.x · Cited by 94

Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier

Tam, V. H., Sosa, C. L., Liu, R., Yao, N., & Priestley, R. D. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.031 · Cited by 97

Bioengineering Strategies for Designing Targeted Cancer Therapies

Alexander-Bryant, A. A., Berg-Foels, W. S. V., & Wen, X. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407173-5.00002-9 · Cited by 100

Development and Characterization of Niosomal Formulations of Doxorubicin Aimed at Brain Targeting

Bragagni, M., Mennini, N., Ghelardini, C., & Mura, P. (2012) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3230m · Cited by 93

Application of nanoparticles for the delivery of drugs to the brain

Kreuter, J. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.014 · Cited by 107

Transport of drugs across the blood–brain barrier by nanoparticles.

Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715

Use of nanoparticles to deliver therapeutics to the CNS

Kreuter, J. (2010) · Frontiers in Pharmacology · doi:10.3389/conf.fphar.2010.02.00024

Influence of the Surface Properties on Nanoparticle-Mediated Transport of Drugs to the Brain

Kreuter, J. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2003.077 · Cited by 363

Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (bbb).

Kreuter, J. (2013) · Journal of Microencapsulation · doi:10.3109/02652048.2012.692491 · Cited by 172